Overview of the Safety of Anti-VEGF Drugs: Analysis of the Italian Spontaneous Reporting System

ConclusionsThis study documented that serious ADRs and systemic toxicity may occur not only with systemic use of anti-VEGF drugs in patients with cancer but also with intravitreal administration. Close monitoring of cardio/cerebrovascular adverse events should be considered during treatment with all anti-VEGF drugs.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research